Engitix Therapeutics
Mario Strazzabosco is Professor of Medicine (Digestive Diseases) at the Yale Medical School and the Director and Clinical Program Leader of the Smilow Liver Cancer Program and the Deputy Director of the Yale Liver Center, New Haven, USA. He is internationally recognised as an expert in advanced hepatology and liver cancer.
This person is not in the org chart
This person is not in any offices
Engitix Therapeutics
To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.